p63-negative thoracic NUT carcinoma - A potential diagnostic pitfall.

Indian J Pathol Microbiol

Department of Pathology, Regional Cancer Centre, Thiruvananthapuram, Kerala, India.

Published: June 2025


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

NUT carcinoma is a rare, aggressive, undifferentiated carcinoma characterized by NUTM1 gene rearrangement. It was formerly termed NUT midline carcinoma due to its propensity to occur in midline anatomical structures. While initially believed to affect children and young adults predominantly, subsequent research has revealed its capacity to affect individuals of any age, without gender predilection. NUT carcinoma has been included in the 2015 WHO classification of thoracic tumors. NUT carcinoma can be difficult to distinguish from poorly differentiated tumors, often requiring immunohistochemistry (IHC) or molecular studies for diagnosis. The diagnostic immunohistochemical staining for NUT carcinoma is the NUT antibody. NUT carcinoma is usually positive for p63 IHC. Rare instances of p63-negative NUT carcinoma have been documented, particularly in the thoracic region. Here, we present a unique case of p63-negative thoracic NUT carcinoma, emphasizing the potential diagnostic pitfall.

Download full-text PDF

Source
http://dx.doi.org/10.4103/ijpm.ijpm_493_24DOI Listing

Publication Analysis

Top Keywords

nut carcinoma
32
nut
10
carcinoma
10
p63-negative thoracic
8
thoracic nut
8
potential diagnostic
8
diagnostic pitfall
8
carcinoma potential
4
pitfall nut
4
carcinoma rare
4

Similar Publications

Complete Response to BET Inhibitor in Primary Pulmonary NUT Carcinoma With Single-Cell Sequencing-Based Analysis: A Case Report.

JTO Clin Res Rep

October 2025

Clinical Research Center (CRC), Medical Pathology Center (MPC), Cancer Early Detection and Treatment Center (CEDTC), and Translational Medicine Research Center (TMRC), Chongqing University Three Gorges Hospital, Wanzhou District, Chongqing, People's Republic of China.

NUT carcinoma is a rare and highly aggressive malignancy characterized by rapid progression, resistance to conventional therapies, and an extremely poor prognosis. This report presents a 36-year-old patient with stage IIIB primary pulmonary NUT carcinoma who achieved remarkable clinical outcomes with NHWD-870 monotherapy, a novel BET inhibitor. After just 1 month of treatment, imaging revealed a partial response, and a complete response was achieved within 5 months.

View Article and Find Full Text PDF

Although a diagnosis of anaplastic thyroid carcinoma (ATC) can be rendered on fine needle aspiration (FNA), a core needle biopsy is often performed to provide sufficient material for immunohistochemical and molecular analysis. Rendering an ATC diagnosis on core biopsy can be challenging due to limited material. It is crucial that other diagnostic entities in the differential, such as poorly differentiated thyroid carcinoma, medullary thyroid carcinoma, lymphoma, metastases, and NUT carcinoma (among others), are considered and that immunohistochemistry (IHC) is employed judiciously to support the diagnosis.

View Article and Find Full Text PDF

Quantitative screening of geranylgeranoic acid in selected plant-based foods using LC/MS/MS.

Front Nutr

August 2025

Department of Nutritional Health, Nutritional Biochemistry, Faculty of Wellness Studies, Kwassui Women's University, Nagasaki, Japan.

Geranylgeranoic acid (GGA), a bioactive acyclic isoprenoid, has been developed as a preventive agent against recurrent hepatocellular carcinoma. While previous studies have identified GGA in certain medicinal herbs, such as turmeric, its presence in other commonly consumed plant-based foods remains largely unexplored. In this study, we screened 14 plant-based food items using a validated LC/MS/MS method to quantify their GGA content.

View Article and Find Full Text PDF

Bioactive catechins from Potentilla fulgens Wall. ex Sims roots ameliorate oral carcinogenesis through modulation of oxidative stress, inflammatory, and apoptotic pathways.

J Ethnopharmacol

August 2025

Advanced Drug Delivery Laboratory, Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Girijananda Chowdhury University, Guwahati, 781017, Assam, India. Electronic address:

Ethnopharmacological Relevance: Potentilla fulgens (PF) roots commonly known as 'Bajradanti' are widely used by indigenous tribes of Northeast India to treat oral diseases. Pieces of the roots were chewed as herbal remedy along with areca-nut to alleviate its harmful effects. While PF showed anticancer property in the gastrointestinal tract, its effects on oral cancer remain unexplored.

View Article and Find Full Text PDF

We investigate the role of prokineticin, T-reg cells, and oxidative metabolism in the progression of obesity-related NASH to HCC. Our findings on a cohort of 250 patients, including Obese NAFLD and Non-Obese NAFLD, reveal significant insights. In Obese NAFLD, PK-1 mRNA expression was reduced by 2.

View Article and Find Full Text PDF